OLEK ELIZABETH A (SR VP, CLINICAL SCIENCE) sold 3.7% of their position (7.37K shares) of KRONOS BIO, INC. on the open market
Open‑market sale worth $7.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2024ACC: 0001415889-24-005151
Officer· SR VP, CLINICAL SCIENCE
Since Feb 2024
-7.37K
Net shares
Net seller
$7.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.37K
Price / share
$1.05
Trade value
$7.77K
% of position
3.7%
2/21/2024
200.64K→193.28K
Total
Net shares
−7.37K
Net value
-$7.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2024 | S · Sale | −7.37K | $1.05 | $7.77K | 3.7% | 200.64K | 193.28K |
| Total | −7.37K | -$7.77K | ||||||
Derivative Transactions0
No derivative transactions reported